Oncopeptides AB (publ)
Oncopeptides AB (publ)
Your view on ONPPF
Overview
What the company does, where it operates, and who runs it.
About Oncopeptides AB (publ)
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Sofia Heigis
- Headquarters
- Vastra Tradgardsgatan 15, Stockholm, SE
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Sofia Heigis
- Headquarters
- Vastra Tradgardsgatan 15, Stockholm, SE
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.